Publications by authors named "Chiara Raviola"
Article Synopsis
- Pediatric Mastocytosis is a rare disease that leads to an excess of mast cells, causing symptoms like itching and fatigue, particularly affecting children with Systemic Mastocytosis who are at high risk for severe allergic reactions.
- A child suffering from severe Systemic Mastocytosis experienced rapid improvement after being treated with Omalizumab, an anti-IgE monoclonal antibody, allowing for the withdrawal of steroid treatments and other medications.
- Omalizumab proved to be a highly effective and safe option for managing symptoms in children unresponsive to conventional therapies, demonstrating significant benefits in quality of life.
Background and aim It is still unclear whether patients with severe asthma are at greater risk of developing severe COVID-19, particularly pediatric allergic patients under biologic therapy. Studies targeting pediatric patients are currently limited; thus, this study aims to assess the clinical characteristics of young patients with severe asthma under biological therapies during the COVID-19 pandemic. Methods We collected data from February 2020 to April 2021.
View Article and Find Full Text PDF